ArticleJournal of virology2026

Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC.

Qi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.